ロード中...
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized clinical trials accounting for classical risk factors, such as hypertension, diabetes, and serum lipids. However, besides such classical risk f...
保存先:
| 出版年: | J Atheroscler Thromb |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Japan Atherosclerosis Society
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147010/ https://ncbi.nlm.nih.gov/pubmed/33229815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.60087 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|